The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
A clinical drug library screen identifies astemizole as an antimalarial agent
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites
Slater, A. F. G., & Cerami, A. (1992) · Nature · doi:10.1038/355167a0 · Cited by 635
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., & McLeod, H. L. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544030-00005 · Cited by 517
On the molecular mechanism of chloroquine's antimalarial action.
Sullivan, D. J., Gluzman, I. Y., Russell, D. G., & Goldberg, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11865 · Cited by 508
Self-citationPeters, W. (1975) · PubMed · Cited by 488
Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208875 · Cited by 382
Astemizole: A Review of its Pharmacodynamic Properties and Therapeutic Efficacy
Richards, D. M., Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1984) · Drugs · doi:10.2165/00003495-198428010-00003 · Cited by 259
Plasmodium falciparum: Assessment of in vitro growth by [3H]hypoxanthine incorporation
Chulay, J. D., Haynes, J. D., & Diggs, C. L. (1983) · Experimental Parasitology · doi:10.1016/0014-4894(83)90007-3 · Cited by 164
Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells
Traebert, M., Dumotier, B., Meister, L., Hoffmann, P., Dominguez-Estevez, M., & Suter, W. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.003 · Cited by 159
Risks of non-sedating antihistamines
Lindquist, M., & Edwards, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)26018-6 · Cited by 122
Cited by
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
Self-citationDyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 660
Malaria biology and disease pathogenesis: insights for new treatments
Miller, L. H., Ackerman, H. C., Su, X.-Z., & Wellems, T. E. (2013) · Nature Medicine · doi:10.1038/nm.3073 · Cited by 582
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Self-citationInnovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrián, F., Matzen, J. T., Anderson, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802982105 · Cited by 449
Drug combination therapy increases successful drug repositioning
Sun, W., Sanderson, P. E., & Zheng, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.015 · Cited by 436
Jin, G., & Wong, S. T. C. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.005 · Cited by 416
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Shim, J. S., & Liu, J. O. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9224 · Cited by 382
Self-citationDrug repurposing and human parasitic protozoan diseases
Andrews, K. T., Fisher, G., & Skinner-Adams, T. S. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.02.002 · Cited by 383
Drug repurposing for antimicrobial discovery
Farha, M. A., & Brown, E. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0357-1 · Cited by 360
Drug discovery and development for neglected parasitic diseases
Renslo, A. R., & McKerrow, J. H. (2006) · Nature Chemical Biology · doi:10.1038/nchembio837 · Cited by 337
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
Ezzat, A., Wu, M., Li, X.-L., & Kwoh, C.-K. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby002 · Cited by 314
In silico repositioning of approved drugs for rare and neglected diseases
Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Zhou, J., Patel, T. R., Sirianni, R. W., Strohbehn, G., Zheng, M.-Q., Duong, N., Schafbauer, T., Huttner, A. J., Huang, Y., Carson, R. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304504110 · Cited by 271
Self-citationYang, H.-C., Xing, S., Shan, L., O’Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39199 · Cited by 258
Self-citationTomitsuka, E., Kita, K., & Esumi, H. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs041 · Cited by 79
“Recently, PP has been shown to exhibit anti-parasitic activities against some parasite infections, such as cryptosporidiosis and malaria (14, 15), as well as an anticancer-effect on human cancer cell xenografts (10, 16, 17).”
BackgroundHu, Q., Hou, Y.-C., Huang, J., Fang, J.-Y., & Xiong, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0526-0 · Cited by 63
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Kim, K., Zilbermintz, L., & Martchenko, M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0090-4 · Cited by 48
Fuentealba, R. A., Marasa, J., Diamond, M. I., Piwnica-Worms, D., & Weihl, C. C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr500 · Cited by 28
Herrant, M., Loucoubar, C., Bassène, H., Gonçalves, B., Boufkhed, S., Diene Sarr, F., Fontanet, A., Tall, A., Baril, L., Mercereau-Puijalon, O., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002835 · Cited by 15
Metadata
- Authors
- Chong, C. R., Chen, X., Shi, L., Liu, J. O., & Sullivan, D. J.
- Venue
- Nature Chemical Biology
- Published
- 2006-07-02
- Volume
- 2
- Issue
- 8
- Pages
- 415-416
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2008731781
- Cited by
- 289
- References
- 13
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.